Efficacy of Baclofen Vs Naltrexon in Achieving & Maintaining Abstinence in Alcohol Dependence.
Conditions: Alcohol Liver Disease Interventions: Drug: Naltrexon; Drug: Baclofen Sponsors: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2023 Category: Research Source Type: clinical trials
Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease
Conditions: Non-Alcoholic Fatty Liver Disease; Non Alcoholic Fatty Liver; Non Alcoholic Steatohepatitis; NAFLD; NASH Interventions: Drug: Hyperpolarized (HP) 13C; Drug: Hyperpolarized 13C-Urea; Procedure: Magnetic Resonance Imaging; Procedure: Saline Flush Sponsors: Michael Ohliger, MD PhD; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2023 Category: Research Source Type: clinical trials
Effects of Ketone Supplementation on Acute Alcohol Withdrawal
Conditions: Alcohol Use Disorder; Alcohol Withdrawal; Alcohol Dependence; Ketosis Interventions: Dietary Supplement: Kenetik; Ketone Concentrate; Dietary Supplement: Isocaloric dextrose placebo Sponsors: University of Pennsylvania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2023 Category: Research Source Type: clinical trials
To Evaluate the Efficacy and Safety of HSK31679 in Chinese Patients With Non-Alcoholic Steatohepatitis (NASH) .
Conditions: Non-Alcoholic Steatohepatitis (NASH) Interventions: Drug: HSK31679 80mg; Drug: HSK31679 160mg; Drug: Placebo Sponsors: Haisco Pharmaceutical Group Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials
The Metabolic Effects of Ginseng Oligopeptide Preparation on Non- Alcoholic Fatty Liver Disease With Obesity: a Randomized Controlled Double-blind Trial
Conditions: Non-alcoholic Fatty Liver Disease Interventions: Other: Ginseng oligopeptide (Ginseng extract ）; Other: Maltodextrin Sponsors: Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials
Study protocol for a randomized controlled trial of RealConsent2.0: a web-based intervention to promote prosocial alcohol-involved bystander behavior in young men
DiscussionRealConsent2.0 is the first web-based intervention for young men that encourages and teaches skills to engage in prosocial bystander behavior to prevent SV while intoxicated. This is also the first study to assess the proximal effect of alcohol on bystander behavior via a VR environment.Trial registrationClinicaltrials.gov, NCT04912492. Registered on 05 February 2021 (Source: Trials)
Source: Trials - December 12, 2023 Category: Research Source Type: clinical trials
Evaluating a One-Year Version of the Parent-Child Assistance Program
Conditions: Alcohol Use Disorder; Substance Use Disorders; Pregnancy Related; Alcohol Use Complicating Pregnancy, Unspecified Trimester; Fetal Alcohol Syndrome; Fetal Alcohol Spectrum Disorders; Drug Use Disorders; Drug Use Complicating Pregnancy, Unspecified Trimester; Maternal Drugs Affecting Fetus; Maternal; Alcohol Use, Affecting Fetus Interventions: Behavioral: Parent-Child Assistance Program - One-Year Version Sponsors: University of Oklahoma; Children ' s Bureau - Administration for Children and Families; Oklahoma Human Services; Oklahoma Department of Mental Health and Substance Abuse Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder
Conditions: Severe Alcohol Use Disorder Interventions: Drug: Psilocybin (high dose); Drug: Active placebo (low dose of psilocybin) Sponsors: Brugmann University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
Consumer Responses to Alcohol Warnings
Conditions: Alcohol Drinking Interventions: Behavioral: Mouth cancer warning; Behavioral: Throat cancer warning; Behavioral: Voice box (larynx) warning; Behavioral: Esophagus cancer warning; Behavioral: Liver cancer warning; Behavioral: Colon and rectum cancer warning; Behavioral: Breast cancer; Behavioral: Cancer (generic, not site-specific); Behavioral: Addiction and neurological changes; Behavioral: Hypertension; Behavioral: Liver damage; Behavioral: Harm to fetus; Behavioral: Dementia; Behavioral: Impaired sleep; Behavioral: Drinking guidelines; Behavioral: Control; Behavioral: Road injuries Sponsors: Stanford Universi...
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
Study of Liver Fibrosis Stage Assessment by TEP Fibroblast Activation Protein Imaging in Patients With Biopsy for Suspected or Proven Nonalcoholic Steatohepatitis
Conditions: Non-alcoholic Steatohepatitis Interventions: Drug: PET scan of 68Ga-FAPI Sponsors: Central Hospital, Nancy, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
Alcohol & Men's Sexual Risk Behaviors
Conditions: Sexual Behavior; Alcohol Drinking; Sexual Aggression; Emotions Interventions: Behavioral: Alcoholic Beverage; Behavioral: Non-alcoholic Beverage; Behavioral: Partner Negative Mood Manipulation; Behavioral: Partner Positive Mood Manipulation Sponsors: Arizona State University; National Institute on Alcohol Abuse and Alcoholism (NIAAA); Georgia State University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials
Intestinal Microbiota Profiling in Severe Acute Alcoholic Hepatitis Patients
Conditions: Severe Acute Alcoholic Hepatitis; Alcohol; Intestinal Microbiota; Corticosteroids Interventions: Other: stool withdrawal Sponsors: Centre Hospitalier Universitaire, Amiens; CH Montdidier Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials
Role of Extended Low Dose Prednisolone in Achieving Clinical and Biochemical Remission in Steroid Responsive Severe Alcoholic Hepatitis
Conditions: Severe Alcoholic Hepatitis Interventions: Drug: Prednisolone; Other: Standard Medical therapy; Drug: Placebo Sponsors: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials
Clinical Trial Assessing Godex Carnitine Orotate Complex in Nonalcoholic Fatty Liver Disease Patients for Efficacy
Conditions: Non-Alcoholic Fatty Liver Disease Interventions: Drug: GODEX; Drug: Placebo Sponsors: Yoon Jun Kim; Celltrion Pharm, Inc. Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials
A Trial to Learn How Safe AZD9550 is in People With Type 2 Diabetes Who Are Overweight or Obese
Conditions: Non-alcoholic Steatohepatitis (NASH) Interventions: Drug: AZD9550; Drug: Placebo Sponsors: AstraZeneca Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials
